Skip to content

Risk stratification of catheter ablation of atrial fibrillation with regard to intervention-associated complications in the upper gastrointestinal tract

Risk stratification of catheter ablation of atrial fibrillation with regard to intervention-associated complications in the upper gastrointestinal tract - complications upper GI after PVI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036820
Enrollment
800
Registered
2025-11-12
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.9

Interventions

Group 1: Retrospective inclusion of all consecutive patients after pulmonary vein isolation (PVI) of atrial fibrillation (AF) with radiofrequency ablation (RFA) on the posterior wall of the left atriu

Sponsors

Klinikum Oldenburg AöR, Universitätsklinik für Innere Medizin III - Gastroenterologie, Hepatologie, Stoffwechselmedizin, Nieren- und Hochdruckerkrankungen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion of all patients = 18 years of age who have undergone catheter ablation of atrial fibrillation at Klinikum Oldenburg AöR between 1 March 2021 and 30 April 2025

Exclusion criteria

Exclusion criteria: Exclusion of all patients < 18 years of age at the time of the intervention or who have not given written consent for ablation or post-interventional endoscopy

Design outcomes

Primary

MeasureTime frame
Endoscopically detectable esophageal lesions (EDEL) after PVI

Secondary

MeasureTime frame
PVI-associated gastroparesis Atrioesophageal fistula Esophageal perforation Complications of PVI (pericardial effusion, pneumonia, sepsis, access-site complications - bleeding, aneurysm, fistula)

Countries

Germany

Contacts

Public ContactChristian Meinhardt

Klinikum Oldenburg AöR, Universitätsklinik für Innere Medizin III - Gastroenterologie, Hepatologie, Stoffwechselmedizin, Nieren- und Hochdruckerkrankungen

christian.meinhardt@uni-oldenburg.de+4944140477575

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026